INVA Q3 2018 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$62M+26.8% YoY

Gross Profit

$62M100.0% margin

Operating Income

$58M93.5% margin

Net Income

$47M76.3% margin

EPS (Diluted)

$0.43

QoQ Revenue Growth

-8.1%

Cash Flow

Operating Cash Flow

$60M

Free Cash Flow

$60M

Stock-Based Comp.

-$874,000

Balance Sheet

Total Assets

$278M

Total Liabilities

$386M

Stockholders' Equity

-$111M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$49M	+26.8%
Gross Profit	$62M	$48M	+27.6%
Operating Income	$58M	$40M	+44.1%
Net Income	$47M	$24M	+98.1%